BIOMARIN PHARMACEUTICAL INC (BMRN) Net Income (Loss) Attributable to Parent USD 2010 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Biomarin Pharmaceutical Inc Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was $88.7 M, a 74.4% increase year-over-year.
  • Biomarin Pharmaceutical Inc Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was $205 M, a 187% increase year-over-year.
  • Biomarin Pharmaceutical Inc annual Net Income (Loss) Attributable to Parent for 2023 was $168 M, a 18.4% increase from 2022.
  • Biomarin Pharmaceutical Inc annual Net Income (Loss) Attributable to Parent for 2022 was $142 M.
  • Biomarin Pharmaceutical Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$64.1 M, a 108% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $168 M +$26.1 M +18.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 $142 M +$206 M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 -$64.1 M -$918 M -108% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 $854 M +$878 M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 -$23.8 M +$53.4 M +69.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 -$77.2 M +$39.8 M +34% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 -$117 M +$513 M +81.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 -$630 M -$458 M -267% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 -$172 M -$37.8 M -28.2% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-26
2014 -$134 M +$42.4 M +24% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
2013 -$176 M -$62 M -54.2% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 -$114 M -$60.5 M -112% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-02
2011 -$53.8 M -$260 M -126% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-26
2010 $206 M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.